Abstract
Blood transfusion-related adverse reactions have been reported to be caused by leukocytes in blood products. It is now generally accepted that it would be highly desirable to reduce leukocytes level as low as possible. In this study, melt-blown poly(butylene terephthalate) nonwoven (PBT-NW) was treated with a hydroxyapatite (HA) surface-modification method for removal of leukocytes from blood components. Acrylic acid was graft-polymerized onto the surface of the PBT-NW after oxygen plasma glow discharge treatment. The PBT-NW surface was covered with a thin layer of HA produced by immersing the polymer surface in an aqueous solution containing high concentrations of PO(4) (3-) and Ca(2+) after graft-polymerization of acrylic acid, which provided the nucleus for HA crystallization. The surface was characterized using water contact angles, attenuated total reflection-Fourier transform infrared (ATR-FT-IR), and electron spectroscopy for chemical analysis. When filtration was performed with a unit of red blood cell concentrates, HA-deposited PBT-NW (PBT-HA) removed 98.5% of the leukocytes and recovered 99.5% of the erythrocytes, suggesting that HA-deposited PBT-NW is a very promising blood filter for selective removal of leukocytes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of Biomedical Materials Research Part B: Applied Biomaterials
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.